Zi-xuan Wang, Ph.D. - Publications

Affiliations: 
2002 University of Louisville, Louisville, KY, United States 
Area:
Molecular Biology, Cell Biology, Microbiology Biology

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chao T, Wang ZX, Bowne WB, Yudkoff CJ, Torjani A, Swaminathan V, Kavanagh TR, Roadarmel A, Sholevar CJ, Cannaday S, Krampitz G, Zhan T, Gorgov E, Nevler A, Lavu H, et al. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. Archives of Pathology & Laboratory Medicine. PMID 38452805 DOI: 10.5858/arpa.2023-0005-OA  0.429
2021 Gargano SM, Badjatia N, Nikolaus Y, Peiper SC, Wang ZX. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis. Acta Medica Academica. 50: 4-12. PMID 34075760 DOI: 10.5644/ama2006-124.322  0.433
2020 Shen H, Wang GC, Li X, Ge X, Wang M, Shi ZM, Bhardwaj V, Wang ZX, Zinner RG, Peiper SC, Aplin AE, Jiang BH, He J. S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer. Oncogene. PMID 33037411 DOI: 10.1038/s41388-020-01497-4  0.449
2020 Jin R, Pettengill MA, Hartnett NL, Auerbach HE, Peiper SC, Wang Z. Commercial SARS-CoV-2 Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG Cov Extended Panel and ID NOW COVID-19 Test. Archives of Pathology & Laboratory Medicine. PMID 32649229 DOI: 10.5858/Arpa.2020-0283-Sa  0.503
2020 Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, Mouchtouris N, Philipp L, Peiper SC, Wang ZX, Rincon F, Tjoumakaris SI, Jabbour P, Rosenwasser RH, Gooch MR. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32354770 DOI: 10.1136/Jnnp-2020-323522  0.421
2018 Neill T, Andreuzzi E, Wang ZX, Peiper SC, Mongiat M, Iozzo RV. Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature. The Journal of Biological Chemistry. PMID 29921586 DOI: 10.1074/Jbc.Ra118.002934  0.474
2016 Brody JR, Yabar CS, Zarei M, Bender J, Matrisian LM, Rahib L, Heartwell C, Mason K, Yeo CJ, Peiper SC, Jiang W, Varieur K, Madhavan S, Petricoin E, Fortuna D, ... ... Wang ZX, et al. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer. Cancer Biology & Therapy. 0. PMID 27466707 DOI: 10.1080/15384047.2016.1210743  0.462
2016 Palmer J, Shukla G, Mollaee M, Sharma D, Skowronski J, Bhamidipati D, Champ C, Glass J, Kim L, Judy K, Evans J, Farrell C, Andrews D, Peiper S, Shi W, ... Wang Z, et al. NIMG-67. PRE-RADIATION TUMOR PROGRESSION IMPROVES PROGNOSTIC STRATIFICATION IN GLIOBLASTOMA PATIENTS Neuro-Oncology. 18: vi139-vi139. DOI: 10.1093/Neuonc/Now212.578  0.481
2016 Peiper SC, Johnson E, Wang Z. Sequencing the Snark Comparison of Whole-Genome Sequencing Strategies for the Detection of Somatic Mutations in Cancer Clinical Omics. 3: 24-26. DOI: 10.1089/Clinomi.03.05.09  0.499
2016 Peiper SC, Wang Z. Breast Cancer YAPI (Yet Another Prognostic Indicator) Revisited: American Society of Clinical Oncology Recommendations Clinical Omics. 3: 22-23. DOI: 10.1089/Clinomi.03.04.08  0.474
2016 Peiper SC, Wang Z. Beyond A C G T Clinical Omics. 3: 18-19. DOI: 10.1089/Clinomi.03.01.07  0.487
2015 Uppal G, Ly V, Wang ZX, Bajaj R, Solomides CC, Banks PM, Medeiros LJ, Peiper SC, Gong JZ. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia. American Journal of Clinical Pathology. 143: 120-5. PMID 25511150 DOI: 10.1309/Ajcpqlq89Vxtvwkn  0.439
2015 Simen BB, Yin L, Goswami CP, Davis KO, Bajaj R, Gong JZ, Peiper SC, Johnson ES, Wang ZX. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory. Archives of Pathology & Laboratory Medicine. 139: 508-17. PMID 25356985 DOI: 10.5858/Arpa.2013-0710-Oa  0.459
2015 Mardekian SK, Solomides CC, Gong JZ, Peiper SC, Wang ZX, Bajaj R. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors. Journal of Clinical Laboratory Analysis. 29: 462-8. PMID 25132285 DOI: 10.1002/Jcla.21794  0.438
2015 Ly V, Bajaj R, Gong J, Wang Z, Peiper S, Uppal G. t(3;8)(q26;q24) With MYC Rearrangement in Acute Myeloid Leukemia: A Case Report American Journal of Clinical Pathology. 144: A119-A119. DOI: 10.1093/Ajcp/144.Suppl2.119  0.479
2015 Peiper SC, Wang Z. Molecularly Targeted Agents in Personalized Cancer Therapy and Diagnostics Clinical Omics. 2: 18-19. DOI: 10.1089/Clinomi.02.11.07  0.476
2015 Peiper SC, Wang ZX. The Pons Asinorum of Diagnostic Genomics Genetic Engineering and Biotechnology News. 35. DOI: 10.1089/Clinomi.02.10.08  0.463
2014 Jamal SE, Li S, Bajaj R, Wang Z, Kenyon L, Glass J, Pang CS, Bhagavathi S, Peiper SC, Gong JZ. Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases. Brain Tumor Pathology. 31: 265-73. PMID 24399201 DOI: 10.1007/S10014-013-0173-X  0.439
2013 Gong P, Metrebian F, Dulau-Florea A, Wang ZX, Bajaj R, Gulati G, Peiper SC, Gong JZ. Aberrant expression of CD56 on granulocytes and monocytes in myeloproliferative neoplasm Journal of Hematopathology. 6: 127-134. DOI: 10.1007/S12308-013-0190-Z  0.494
2012 Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis. Acta Cytologica. 56: 645-54. PMID 23207443 DOI: 10.1159/000343473  0.488
2012 Buraschi S, Neill T, Owens RT, Iniguez LA, Purkins G, Vadigepalli R, Evans B, Schaefer L, Peiper SC, Wang ZX, Iozzo RV. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. Plos One. 7: e45559. PMID 23029096 DOI: 10.1371/Journal.Pone.0045559  0.529
2010 Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K. Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists. Blood. 116: 5306-15. PMID 20810927 DOI: 10.1182/Blood-2010-05-284414  0.488
2010 Sharma S, Free A, Mei Y, Peiper SC, Wang Z, Cowell JK. Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. Experimental and Molecular Pathology. 89: 169-74. PMID 20621092 DOI: 10.1016/J.Yexmp.2010.06.009  0.443
2009 Tanaka T, Nomura W, Narumi T, Esaka A, Oishi S, Ohashi N, Itotani K, Evans BJ, Wang ZX, Peiper SC, Fujii N, Tamamura H. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids. Organic & Biomolecular Chemistry. 7: 3805-9. PMID 19707686 DOI: 10.1039/B908286G  0.505
2009 Evans BJ, Wang Z, Broach JR, Oishi S, Fujii N, Peiper SC. Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists. Methods in Enzymology. 460: 399-412. PMID 19446737 DOI: 10.1016/S0076-6879(09)05220-3  0.573
2009 Tamamura H, Tanaka T, Tsutsumi H, Ohashi N, Hiramatsu K, Araki T, Ojida A, Hamachi I, Wang Z, Peiper SC, Trent JO, Ueda S, Oishi S, Fujii N. Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy. Advances in Experimental Medicine and Biology. 611: 145-6. PMID 19400132 DOI: 10.1007/978-0-387-73657-0_65  0.535
2008 Evans BJ, Wang Z, Mobley L, Khosravi D, Fujii N, Navenot JM, Peiper SC. Physical association of GPR54 C-terminal with protein phosphatase 2A. Biochemical and Biophysical Research Communications. 377: 1067-71. PMID 18977201 DOI: 10.1016/J.Bbrc.2008.10.108  0.527
2008 Ueda S, Kato M, Inuki S, Ohno H, Evans B, Wang ZX, Peiper SC, Izumi K, Kodama E, Matsuoka M, Nagasawa H, Oishi S, Fujii N. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach. Bioorganic & Medicinal Chemistry Letters. 18: 4124-9. PMID 18539453 DOI: 10.1016/J.Bmcl.2008.05.092  0.493
2008 Romero-Sánchez M, Peiper SC, Evans B, Wang Z, Catasús L, Ribe A, Prat J, Giri JG. Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors. Human Pathology. 39: 1026-33. PMID 18479732 DOI: 10.1016/J.Humpath.2007.11.007  0.548
2008 Oishi S, Masuda R, Evans B, Ueda S, Goto Y, Ohno H, Hirasawa A, Tsujimoto G, Wang Z, Peiper SC, Naito T, Kodama E, Matsuoka M, Fujii N. Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4. Chembiochem : a European Journal of Chemical Biology. 9: 1154-8. PMID 18412193 DOI: 10.1002/Cbic.200700761  0.554
2007 Lipan O, Navenot JM, Wang Z, Huang L, Peiper SC. Heat shock response in CHO mammalian cells is controlled by a nonlinear stochastic process. Plos Computational Biology. 3: 1859-70. PMID 17922567 DOI: 10.1371/Journal.Pcbi.0030187  0.486
2007 Tomita K, Oishi S, Cluzeau J, Ohno H, Navenot JM, Wang ZX, Peiper SC, Akamatsu M, Fujii N. SAR and QSAR studies on the N-terminally acylated pentapeptide agonists for GPR54. Journal of Medicinal Chemistry. 50: 3222-8. PMID 17579384 DOI: 10.1021/Jm070064L  0.558
2007 Cluzeau J, Oishi S, Ohno H, Wang Z, Evans B, Peiper SC, Fujii N. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists. Organic & Biomolecular Chemistry. 5: 1915-23. PMID 17551641 DOI: 10.1039/B702649H  0.521
2007 Ueda S, Oishi S, Wang ZX, Araki T, Tamamura H, Cluzeau J, Ohno H, Kusano S, Nakashima H, Trent JO, Peiper SC, Fujii N. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities. Journal of Medicinal Chemistry. 50: 192-8. PMID 17228861 DOI: 10.1021/Jm0607350  0.553
2007 Napier KB, Wang ZX, Peiper SC, Trent JO. CCR5 interactions with the variable 3 loop of gp120. Journal of Molecular Modeling. 13: 29-41. PMID 16721558 DOI: 10.1007/S00894-006-0117-Z  0.505
2007 Mandawat A, Fiskus W, Jakubowski A, Rao R, Wang Z, Fernandez P, Wang Y, Lee P, Jillela A, Atadja P, Fujii N, Peiper SC, Bhalla K. Pan-Histone Deacetylase (HDAC) Inhibitor LBH589 Depletes CXCR4 Levels and Signaling, Exerting Synergistic Anti-Leukemia Activity in Combination with CXCR4 Antagonists. Blood. 110: 537-537. DOI: 10.1182/Blood.V110.11.537.537  0.527
2006 Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorganic & Medicinal Chemistry. 14: 7595-603. PMID 16879969 DOI: 10.1016/J.Bmc.2006.07.009  0.574
2006 Navenot JM, Wang ZX, Peiper SC. Characterization of constitutively active mutants of G protein-coupled receptors. Methods in Molecular Biology (Clifton, N.J.). 332: 129-39. PMID 16878689 DOI: 10.1385/1-59745-048-0:129  0.548
2006 Wang ZX, Broach JR, Peiper SC. Functional expression of CXCR4 in Saccharomyces cerevisiae in the development of powerful tools for the pharmacological characterization of CXCR4. Methods in Molecular Biology (Clifton, N.J.). 332: 115-27. PMID 16878688 DOI: 10.1385/1-59745-048-0:115  0.56
2006 Tamamura H, Tsutsumi H, Masuno H, Mizokami S, Hiramatsu K, Wang Z, Trent JO, Nakashima H, Yamamoto N, Peiper SC, Fujii N. Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. Organic & Biomolecular Chemistry. 4: 2354-7. PMID 16763678 DOI: 10.1039/B603818B  0.531
2006 Niida A, Tanigaki H, Inokuchi E, Sasaki Y, Oishi S, Ohno H, Tamamura H, Wang Z, Peiper SC, Kitaura K, Otaka A, Fujii N. Stereoselective synthesis of 3,6-disubstituted-3,6-dihydropyridin-2-ones as potential diketopiperazine mimetics using organocopper-mediated anti-SN2' reactions and their use in the preparation of low-molecule CXCR4 antagonists. The Journal of Organic Chemistry. 71: 3942-51. PMID 16674071 DOI: 10.1021/Jo060390T  0.517
2006 Niida A, Wang Z, Tomita K, Oishi S, Tamamura H, Otaka A, Navenot JM, Broach JR, Peiper SC, Fujii N. Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity. Bioorganic & Medicinal Chemistry Letters. 16: 134-7. PMID 16242330 DOI: 10.1016/J.Bmcl.2005.09.054  0.583
2005 Tamamura H, Esaka A, Ogawa T, Araki T, Ueda S, Wang Z, Trent JO, Tsutsumi H, Masuno H, Nakashima H, Yamamoto N, Peiper SC, Otaka A, Fujii N. Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds. Organic & Biomolecular Chemistry. 3: 4392-4. PMID 16327900 DOI: 10.1039/B513145F  0.543
2005 Navenot JM, Wang Z, Chopin M, Fujii N, Peiper SC. Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Research. 65: 10450-6. PMID 16288036 DOI: 10.1158/0008-5472.Can-05-1757  0.543
2005 Hu Q, Napier KB, Trent JO, Wang Z, Taylor S, Griffin GE, Peiper SC, Shattock RJ. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. Journal of Molecular Biology. 350: 699-712. PMID 15964018 DOI: 10.1016/J.Jmb.2005.05.024  0.535
2005 Tamamura H, Araki T, Ueda S, Wang Z, Oishi S, Esaka A, Trent JO, Nakashima H, Yamamoto N, Peiper SC, Otaka A, Fujii N. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds. Journal of Medicinal Chemistry. 48: 3280-9. PMID 15857134 DOI: 10.1021/Jm050009H  0.559
2005 Tamamura H, Hiramatsu K, Ueda S, Wang Z, Kusano S, Terakubo S, Trent JO, Peiper SC, Yamamoto N, Nakashima H, Otaka A, Fujii N. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. Journal of Medicinal Chemistry. 48: 380-91. PMID 15658852 DOI: 10.1021/Jm049429H  0.517
2005 Bhonsle JB, Wang ZX, Tamamura H, Fujii N, Peiper SC, Trent JO. A simple, automated quasi-4D-QSAR, quasi-multi way PLS approach to develop highly predictive QSAR models for highly flexible CXCR4 inhibitor cyclic pentapeptide ligands using scripted common molecular modeling tools Qsar and Combinatorial Science. 24: 620-630. DOI: 10.1002/Qsar.200430912  0.524
2004 Tamamura H, Mizumoto M, Hiramatsu K, Kusano S, Terakubo S, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N. Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides. Organic & Biomolecular Chemistry. 2: 1255-7. PMID 15064805 DOI: 10.1039/B401485P  0.529
2003 Tamamura H, Hiramatsu K, Mizumoto M, Ueda S, Kusano S, Terakubo S, Akamatsu M, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N. Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists. Organic & Biomolecular Chemistry. 1: 3663-9. PMID 14649897 DOI: 10.1039/B306613B  0.549
2003 Tamamura H, Hiramatsu K, Kusano aS, Terakubo S, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N. Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives. Organic & Biomolecular Chemistry. 1: 3656-62. PMID 14649896 DOI: 10.1039/B306473P  0.548
2003 Trent JO, Wang ZX, Murray JL, Shao W, Tamamura H, Fujii N, Peiper SC. Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists. The Journal of Biological Chemistry. 278: 47136-44. PMID 12958314 DOI: 10.1074/Jbc.M307850200  0.547
2003 Fujii N, Oishi S, Hiramatsu K, Araki T, Ueda S, Tamamura H, Otaka A, Kusano S, Terakubo S, Nakashima H, Broach JA, Trent JO, Wang ZX, Peiper SC. Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries. Angewandte Chemie (International Ed. in English). 42: 3251-3. PMID 12876735 DOI: 10.1002/Anie.200351024  0.527
1997 Peiper SC, Lu ZH, Zhang TY, Wang ZX. [5] Chimeric chemokine receptors for analysis of structure-function relationships Methods in Enzymology. 288: 56-70. PMID 9356987 DOI: 10.1016/S0076-6879(97)88007-X  0.529
Show low-probability matches.